BTLA and neoplasm: While blockade of PD-1 or PD-L1 in combination with IL PV-10 therapy led to anti-tumor immunity in murine melanoma, many CD8+ T cells infiltrating tumors express other co-inhibitory molecules including Tim3, Lag3, CD160, CD244 and BTLA [22–25].